J&J Talc Suit Tally: $6.48 B Offer, $11 B Reserves, $700 M to States — Plus New Class Action and Talc-Cancer Evidence

Spilled Talc Powder J&j Story Update Adobe Stock 804366889
Image by Mohammed at Adobe Stock

In May, Johnson & Johnson (J&J) offered $6.48 billion to resolve more than 99% of ovarian cancer claims. Last week, we reported J&J settled for $700 million with 42 states and Washington, D.C., that were investigating the company's alleged "misleading" marketing. Now the company faces a new class action seeking damages and medical monitoring, as well as evidence from a recent study "supporting a positive association" between intimate care products including genital talc with ovarian cancer. 

Log in to view the full article
More in Regulatory